CERO(Delisted)
CERo Therapeutics·NASDAQ
--
--(--)
Latest data update time: Updated on 2025-10-31
Latest data update time: Updated on 2025-10-31
6.47 / 10Overall Score
OutperformInvestment Rating
6.47 / 10Overall Score
OutperformInvestment Rating
Trend Analysis of CERO
- Based on a composite score of 6.47/10, we rate CERO as a Outperform. Our analysis breaks down into 6.35/10 for Fundamentals, 4.85/10 for Technicals, and 8.20/10 for Sentiment, indicating the stock is likely to See further upside.
Technical Analysis of CERO?
Is CERO undervalued or overvalued?
Is money flowing into or out of CERO?
Trend Analysis of CERO
- Based on a composite score of 6.47/10, we rate CERO as a Outperform. Our analysis breaks down into 6.35/10 for Fundamentals, 4.85/10 for Technicals, and 8.20/10 for Sentiment, indicating the stock is likely to See further upside.
Is CERO undervalued or overvalued?
Technical Analysis of CERO?
Is money flowing into or out of CERO?
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
